Q3 2019 13F Holders as of 9/30/2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
58.6M
-
Number of holders
-
173
-
Total 13F shares, excl. options
-
61.1M
-
Shares change
-
+1.69M
-
Total reported value, excl. options
-
$1.98B
-
Value change
-
+$38.7M
-
Put/Call ratio
-
3.76
-
Number of buys
-
97
-
Number of sells
-
-77
-
Price
-
$32.40
Significant Holders of AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) as of Q3 2019
222 filings reported holding AGIO - AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share as of Q3 2019.
AGIOS PHARMACEUTICALS, INC. - Common Stock, $0.001 par value per share (AGIO) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.1M shares
.
Largest 10 shareholders include FMR LLC (8.81M shares), WELLINGTON MANAGEMENT GROUP LLP (6.71M shares), VANGUARD GROUP INC (4.79M shares), Capital International Investors (4.63M shares), Bellevue Group AG (3.57M shares), BlackRock Inc. (2.91M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.62M shares), STATE STREET CORP (1.85M shares), Invesco Ltd. (1.31M shares), and AMERIPRISE FINANCIAL INC (1.3M shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.